Issues pertaining to pharmaceutical supply chain and manufacturing Medicare related to biosimilars
H.R. 4455 - The BIOSIM Act Passed the House as part of H.R. 3. 
Appropriations included in Committee report H.R. 2740; included also in FY 2021 Labor-H Committee report. 
H.R. 6179/S. 4134 - Increasing Access to Biosimilars Act of 2020
H.R. 4597/S. 3466 - The ACCESS Act
H.R. 8624 - Protecting Access to Innovation during COVID-19 Act
S. 4295  Public Health Emergency Pass-Through Payment Fairness Act
Most Favored Nation Model for Medicare Part B Drugs and Biologicals Interim Final Rule
GOV - Government Issues HCR - Health Issues
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 10 - Vice President of the U.S. 12 - White House Office 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 10 - Vice President of the U.S. 12 - White House Office
COHERUS BIOSCIENCES, INC.
333 Twin Dolphin Drive, Suite 600, Redwood City, CA, 94065, US
DAVID SANDERS DAVID SANDERS (Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000))
Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)